Guggenheim Maintains Buy on Eli Lilly, Raises Price Target to $884
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Seamus Fernandez maintains a Buy rating on Eli Lilly (NYSE:LLY) and raises the price target from $855 to $884.
August 05, 2024 | 6:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guggenheim analyst Seamus Fernandez maintains a Buy rating on Eli Lilly and raises the price target from $855 to $884.
The raised price target and maintained Buy rating from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100